Intensive Care Medicine

, 26:S165 | Cite as

Procalcitonin (PCT) in patients with abdominal sepsis

  • H. B. Reith
  • U. Mittelkötter
  • R. Wagner
  • A. Thiede



To assess the accuracy of procalcitonin as a measure of severity in patients with septic abdominal illnesses and the sepsis syndrome, to compare measurements with those of other inflammatory mediators, and to predict outcome.


We carried out a prospective clinical study from 246 patients with infective or septic episodes confirmed at laparotomy and 66 patients undergoing elective operations who acted as controls. Specimens of blood for measurement of cytokine concentrations determination were obtained daily from septic patients. In the control group specimens were obtained before operation, at the end of operation, and on each of the following days until normal recovery (day 10). Every two weeks up to 3 months for patients with metastases, who were being followed up.


Compared with other cytokines such as tumor necrosis factor αa and interleukin 6 procalcitonin was closely related to the development of infective and septic complications. 59 of 246 patients (24%) with sepsis died. Procalcitonin concentrations preoperatively [median 2.05 compared with 4.2 ng/ml (p=0.08)] (Mann-Whitney U-test) did not differ, but those on the days 1,4 and at the end differed significantly [day 1∶4.9 compared with 13.8 ng/ml (p<0.01); day 4∶4.8 compared with 13.0 ng/ml (p<0.01) and 0.4 compared with 13.25 ng/ml (p<0.01) at the end of the study]. In the control group only 7 (1.6%) of all blood samples, were detected outside the normal range (up to 0.8 ng/ml).


Procalcitonin is a new indicator of infection and sepsis. TNF and IL-6 concentrations always rise after major operations and fall in the absence of infection, indicating operative trauma. Procalcitonin is sensitive in detecting infective complications. Under routine conditions the procalcitonin concentrations seems to be valid, reproducible and detectable.

Key words

Peritonitis Sepsis Septic courses Diagnosis Cytokines Procalcitonin 


  1. 1.
    Haupt W, Fritsche H, Hohenberger W, Zirngibl H (1996) Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg 162, p 769PubMedGoogle Scholar
  2. 2.
    Reith HB, Dittrich H, Haarmann W, Smektala R, Dohle J, Kozuschek W (1996) Adjuvante Therapie der Peritonitis und ihrer septischer Verlaufsformen mit Taurolidin—eine prospektive randomisierte Untersuchung. Chir. Gastroenterologie 12, p 358Google Scholar
  3. 3.
    Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT (1992) Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 165, p 886PubMedGoogle Scholar
  4. 4.
    Heuer HO, Darius H, Lohmann HF, Meyer J, Schierenberg M, Treese N (1991) Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 26, p 1381PubMedCrossRefGoogle Scholar
  5. 5.
    Rosman C, Grond J, Buurman WA, et al (1993) Fish oil increases the release of tumour necrosis factor and interleukin-6 and has no effect on the incidence of multiple organ failure in rats with peritonitis. Eur J Surg 159, p 563PubMedGoogle Scholar
  6. 6.
    Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentration in patients with sepsis and infection. Lancet 341, p 515PubMedCrossRefGoogle Scholar
  7. 7.
    Becker KL, Nash DR, Silva OL, Snider RH, Moore CF (1981) Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest 79, p 211PubMedCrossRefGoogle Scholar
  8. 8.
    Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115, p 457PubMedGoogle Scholar
  9. 9.
    Goris RJA, Boekhorst TPA, Nuytinck JKS (1985) Multiple organ failure. Arch Surg 118, p 1109Google Scholar
  10. 10.
    Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, p 1341PubMedGoogle Scholar
  11. 11.
    Beier W (1994) Procalcitonin (ProCt)—ein innovativer Inflammationsparameter mit prognostischen Eigenschaften (editorial). Anästh Intensivmed 36: 18Google Scholar
  12. 12.
    Huttemeier PC, Ritter EF, Benveniste H (1993) Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxin rats. Am J Physiol 265, p 4767Google Scholar
  13. 13.
    Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA (1990) Calcitonin related peptide levels are elevated in patients with sepsis. Surgery 108, p 1097PubMedGoogle Scholar
  14. 14.
    Mimos O, Benoist JF, Edouard AR, Assicot M, Bohoun C, Samii K (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24: 185–188CrossRefGoogle Scholar
  15. 15.
    Brunkhorst FM, Forycki ZF, Beier W, Wagner J (1993) Discrimination of infectious and non-infectious etiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intensive Care 3, p 12Google Scholar
  16. 16.
    Nylen ES, O'Neill WO, Jordan MH, et al (1992) Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 24, p 439PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • H. B. Reith
    • 1
    • 2
  • U. Mittelkötter
    • 1
    • 2
  • R. Wagner
    • 1
  • A. Thiede
    • 1
  1. 1.Department of SurgeryUniversity of WürzburgWürzburgGermany
  2. 2.Department of SurgeryUniversity of BochumBochumGermany

Personalised recommendations